Dr. Brian W. Loggie, Chief, Division of Surgical Oncology

Brian W. Loggie M.D.

Chief, Division of Surgical Oncology

Get in touch
  • Surgical Oncology

About Dr. Loggie


  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Research Excellence icon

    Excellence in Research

  • Mesothelioma Pioneer icon

    Mesothelioma Pioneer

  • Team Leader icon

    Team Leader

  • 20+ Years of Experience icon

    20+ Years of Experience

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

Brian Loggie, M.D., ventured into uncharted waters when in the 1990s he pioneered a mesothelioma treatment often referred to as heated intraperitoneal chemotherapy, or heated chemotherapy.

It was early in Loggie’s medical career that he helped develop the new cancer treatment that combined surgery with the application of heated chemotherapy drugs. The benefits were immediate. The heat made the drugs more effective in killing the various kinds of cancer. As a result, the procedure is now widely used.

Almost 20 years later, he was taking chances again – and seeing immediate results.

Get the Best Treatment

Get help connecting with Dr. Loggie and find the treatment that's best for you.

Get Help Now

Loggie, professor of surgery and director of the Cancer Biology Program at Creighton University Medical Center in Omaha, Nebraska, led a team of doctors and nurses to Haiti immediately following the devastating earthquake of 2010.

The team was in Haiti for 11 days, working 14-hour shifts of trauma surgery under harsh, often deplorable conditions. They repaired orthopedic injuries, treated open and infected fractures, and amputated limbs, all to save lives.

Loggie returned with a new enthusiasm for his practice, treating and studying peritoneal carcinomatosis and peritoneal mesothelioma.

Focus on Peritoneal Mesothelioma

Loggie has authored or co-authored many articles and papers detailing treatments he has developed, many detailing the research of peritoneal mesothelioma.

Peritoneal mesothelioma is a rare form of the disease, representing just 20 percent of all mesothelioma cases. It develops in the lining of the abdominal cavity and is directly related to the inhalation or ingestion of asbestos.

Quick Fact

Before Dr. Loggie joined the team at Creighton University School of Medicine, the hospital had no Division of Surgical Oncology – Loggie founded the program in 2002.

Loggie earned his medical degree from McGill University, in Montreal, Canada. His post-graduate training included an internship with the Department of Surgery at Montreal General Hospital in Montreal, where he later did his residency.


Loggie’s publications focus on malignant peritoneal mesothelioma and other peritoneal cancers, as well as treatment methods for these illnesses. Loggie’s articles have been published in journals such as the Annals of Surgical Oncology and the World Journal of Surgical Oncology.

Disclaimer: Dr. Brian W. Loggie has no professional affiliation with Asbestos.com.

Free VA Claims Assistance

Get Help Now

Qualify for Free Medical Care

See If You Qualify

Get Help Paying for Treatment

Learn More

Tim Povtak, Senior Content Writer at Asbestos.com

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Get Help Contacting Brian W. Loggie

View our resources for patients and families

Get Help Today
Get Your Free Mesothelioma Guide